RAPT Therapeutics, Inc. (RAPT) Financials
Stock symbol RAPT is outdated, potentially delisted? Maybe it is available on other exchange?
RAPT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 173.3 million | 26.3 million |
| Sept. 30, 2023 | 199.7 million | 26.9 million |
| June 30, 2023 | 220.8 million | 21.1 million |
| March 31, 2023 | 248.3 million | 27.9 million |
RAPT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -27.8 million | 4.4 million |
| Sept. 30, 2023 | -22.0 million | 4.3 million |
| June 30, 2023 | -29.0 million | 4.2 million |
| March 31, 2023 | -19.4 million | 4.1 million |
RAPT Net Income
No data available :(
RAPT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 158.9 million | - | 6.9 million |
| Sept. 30, 2023 | 184.8 million | - | 7.5 million |
| June 30, 2023 | 205.0 million | - | 8.0 million |
| March 31, 2023 | 231.6 million | - | 8.5 million |
RAPT Shares Outstanding
RAPT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 67000 | 26.8 million | 6.5 million | -323000 |
| Sept. 30, 2023 | 66000 | 27.0 million | 6.9 million | - |
| June 30, 2023 | 233000 | 21.6 million | 6.7 million | - |
| March 31, 2023 | 759000 | 25.6 million | 6.0 million | - |
RAPT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | 323000 |
| Sept. 30, 2023 | - | 908000 |
| June 30, 2023 | - | 853000 |
| March 31, 2023 | - | 883000 |
RAPT
Price: $58.02
52 week price:
Earnings Per Share: -11.66 USD
P/E Ratio: -4.98
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 309600
Market Capitalization: 959.5 million